| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5588069 | Journal of Diabetes and its Complications | 2017 | 35 Pages |
Abstract
Exenatide QW improved glycemic outcomes and was well tolerated in patients with T2D for up to 156Â weeks.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Michael E. Trautmann, Luc Van Gaal, Jenny Han, Elise Hardy,